<DOC>
	<DOC>NCT00243295</DOC>
	<brief_summary>To assess the feasibility of using rhBMP-2/CPM in OWO as a surgical model for pharmacodynamic studies, with assessment of the following parameters: - Injecting the desired volume of rhBMP-2/CPM within the defect - Conducting longitudinal radiographic absorptiometry of the tibial defect in the presence of rhBMP-2/CPM.</brief_summary>
	<brief_title>Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Male or female subjects 45 to 70 years of age Within 96 hours prior to dosing, the subject underwent a successful open wedge tibial osteotomy to correct medial compartment OA of the knee. Female subjects of childbearing potential must have a negative pregnancy test (hospital acceptable test), upon hospitalization for OWO and agree to use medically approved contraception for the duration of the study. Other inclusion applies. Subjects with preexisting conditions of the knee or tibia that would confound an interpretation of results. Subjects for whom surgery in the opposite knee is planned during the 6 months of followup. Subjects with a history of malignancy or radiotherapy or chemotherapy for malignancy within the past 5 years, except subjects with a history of basal skin carcinoma. Other exclusion applies.</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>deformity of knee</keyword>
</DOC>